Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

COVID-19 Vaccines and therapeutics.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      United States. Food & Drug Administration ; World Health Organization
    • Abstract:
      المقال يركز على تطوير وتقييم لقاحات وعلاجات COVID-19 استجابة للجائحة التي caused by فيروس كورونا المتلازمة التنفسية الحادة 2 (SARS-CoV-2). يناقش الموافقة على ريمديسيفير كأول علاج معتمد من إدارة الغذاء والدواء الأمريكية (FDA) لـ COVID-19 ويبرز الأبحاث الجارية حول مختلف الأساليب العلاجية ومرشحي اللقاحات. تتضمن المراجعة معلومات مفصلة عن مراحل تطوير اللقاح، وآليات عمل اللقاحات المختلفة، والنتائج من التجارب السريرية، خاصة للقاحات مثل تلك التي طورتها فايزر وموديرنا. يؤكد على أهمية إعادة استخدام الأدوية المضادة للفيروسات الموجودة والحاجة إلى استراتيجيات علاجية فعالة لإدارة COVID-19. [Extracted from the article]
    • Abstract:
      The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first appeared in Wuhan, China, gave rise to the coronavirus disease 2019 (COVID-19), a highly contagious and pathogenic viral infection. COVID-19 is not currently being treated with a specific therapy. Remdesivir is the first medication to be approved by the Food and Drug Administration (FDA) to treat COVID-19. However, numerous alternative therapy modalities are being looked for as COVID-19 therapies. As part of this review, we discussed the development of various drugs, their mechanism of action, and how they might be applied to different cases of COVID-19 patients. This review also offers an update on the development of novel COVID-19 preventive or therapeutic vaccines. We aimed to include the most recent published data from phase III trials about various COVID-19 vaccines and include clinical data made available on networks or peer-reviewed journals in addition to vaccines approved by the Food and Drug Administration (FDA) or The World Health Organization (WHO). [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Journal of College of Education for Pure Science is the property of Republic of Iraq Ministry of Higher Education & Scientific Research (MOHESR) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)